Apt L, Henrick A
Am J Ophthalmol. 1980 Apr;89(4):553-9. doi: 10.1016/0002-9394(80)90065-3.
We studied the mydiatic effect of three solutions containing a combination of two mydriatic drugs in 80 adult patients. The solutions tested were cyclopentolate HCl 0.5% with phenylephrine 2.5%, tropicamide 0.5% with phenylephrine 2.5%, and tropicamide 1.0% with phenylephrine 2.5%. We evaluated the effect of prior instillation of proparacaine 0.5% eyedrops. All three mydriatic combination solutions evaluated produced pupillary dilatation of about 7 mm within 60 minutes. Additional pupillary dilatation of 1 mm occurred when proparacaine was instilled before the mydriatic combination eyedrop. Mydriasis was resistant to bright light during indirect ophthalmoscopy in all patients. Pupils of younger patients dilated better than those of older patients, but sex and iris color were factors in the amount of pupillary dilatation obtained. Wide and sustained pupillary dilatation can be obtained for satisfactory indirect ophthalmoscopy by the instillation of one drop of proparacaine solution followed by a single drop of any of the three mydriatic combination solutions evaluated. By eliminating the need for multiple instillations of drugs, the use of a single eyedrop mydriatic combination is convenient in terms of time saved and also lessens the change of systemic drug toxicity.
我们在80例成年患者中研究了三种含有两种散瞳药物组合的溶液的散瞳效果。所测试的溶液为0.5%盐酸环喷托酯与2.5%去氧肾上腺素、0.5%托吡卡胺与2.5%去氧肾上腺素以及1.0%托吡卡胺与2.5%去氧肾上腺素。我们评估了预先滴入0.5%丙美卡因滴眼液的效果。所评估的所有三种散瞳组合溶液在60分钟内均使瞳孔扩大至约7毫米。在散瞳组合滴眼液之前滴入丙美卡因时,瞳孔额外扩大了1毫米。在所有患者的间接检眼镜检查过程中,散瞳对强光有抵抗作用。年轻患者的瞳孔比老年患者的瞳孔扩张得更好,但性别和虹膜颜色是获得的瞳孔扩张量的影响因素。通过滴入一滴丙美卡因溶液,然后再滴入所评估的三种散瞳组合溶液中的任何一种,可以获得广泛且持续的瞳孔扩张,以进行满意的间接检眼镜检查。通过无需多次滴入药物,使用单滴散瞳组合在节省时间方面很方便,并且还减少了全身药物毒性的发生。